Atlas Genetics Ltd 1.9

Atlas Genetics Ltd is an innovative, UK-based diagnostics company. Atlas Genetics are currently developing the io™ Point-of-Care (POC) platform which will revolutionise patient testing by providing clinicians and healthcare professionals with accurate, actionable test results in around 30 minutes.

The Atlas io™ multi-test system comprises a small, low cost, easy to use instrument (the io™ Reader) and a test-specific disposable (the io™ Cartridge). Following simple addition of the raw patient specimen to the Cartridge, the Cartridge is then inserted in to the Reader. The user follows a few on-screen prompts to start the test which is then performed under complete instrument control, with no further user intervention required. The io™ system provides fully customisable user control settings, end-to-end specimen tracking, hospital/laboratory information system connectivity and an internal process control which is automatically performed with every test to verify the test result.

Atlas’s initial focus is on Sexually Transmitted Infections (STIs) where the io™ platform allows clinicians to make informed treatment decisions in a single patient visit to a clinic, improving patient outcomes and reducing the spread of infection. Atlas are also developing products to test for Hospital Acquired Infections (HAIs).

STD product pipeline:

- Chlamydia
- Chlamydia & Gonorrhoea
- Trichomonas vaginalis
- Mycoplasma genitalium
- Multiplex STI (multiplex of above)

HAI product pipeline:

- MRSA
- C. difficile